1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Mental Health Market Trends
  5. > CNS Drug News 18 APRIL 2016

CNS Drug News 18 APRIL 2016

  • April 2016
  • -
  • Espicom Business Intelligence
  • -
  • 16 pages

Industry Trend Analysis - Demand For Vivitrol Will Rise As US Increases Efforts To Curb Opioid Epidemic
Industry Brief - Xadago Launched In Belgium To Treat Mid-To Late-Stage PD
Industry Brief - Aeolus Secures European/Japanese Patent Covering PD Compound AEOL 11114
Industry Trend Analysis - AstraZeneca And Eli Lilly Accelerate Alzheimer's Drug Development
Industry Trend Analysis - AD Acquisition Heralds Allergan's New Strategy To Drive Growth
Industry Brief - FDA ODD For ANAVEX 3-71 To Treat Frontotemporal Dementia
Industry Brief - Aricept Approved In Philippines To Treat Dementia With Lewy Bodies
Industry Trend Analysis - Dr Reddy's Sees New Horizon In XP23829
Industry Trend Analysis - EU Glatiramer Approval Positions Synthon To Compete With Sandoz
Industry Brief - Lupin Launches Zolpidem Sublingual Tablets
Industry Brief - Benjorna Yields Positive Outcomes In Phase III ADHD Trials
Industry Brief - Shire Seeks FDA Approval For New Formulation Of Vyvanse
Industry Brief - FDA Advises To Amend Posimir Phase III PERSIST Trial Programme
Industry Trend Analysis - FTC Intervention Threatens Generic Marketing Exclusivity Period Value
Industry Trend Analysis - Remoxy Will Struggle In Changing Opioid Market
Industry Brief - Promius Pharma Launches Sumatriptan Product
Industry Brief - Enrolment Target Reached In CAM2038 Phase III Trials To Treat Opioid Dependence
Industry Trend Analysis - Expanding In Niche Indications Will Help Boost Epidiolex Success
Industry Brief - FDA Grants Ganaxolone ODD Status
Industry Brief - MedDay Secures Funding To Advance MD1003 Development In MS
Industry Brief - Martindale Pharma Enters Distribution Deal In Ireland
Industry Brief - CNS Conferences - July 2016

Table Of Contents

CNS Drug News 18 APRIL 2016

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Substance Abuse Treatment Market: By Addiction Substances (Alcohol, Drugs, Cigarettes and Coffee); By Category (Alcohol, Nicotine Dependence Therapeutics, Drug Abuse Therapeutics) & By Region -Forecast (2016-2021)

Substance Abuse Treatment Market: By Addiction Substances (Alcohol, Drugs, Cigarettes and Coffee); By Category (Alcohol, Nicotine Dependence Therapeutics, Drug Abuse Therapeutics) & By Region -Forecast (2016-2021)

  • $ 5250
  • Industry report
  • September 2016
  • by Industry ARC

Alcoholism and drug dependence and addiction, known as substance use disorders and rehabilitation treatments are classified as substance abuse treatment. Some of the common symptoms of drug abuse are ...

Psychotherapeutic Drugs Market: By Type (Antipsychotics, Antidepressants, Antimaniacs, and Anxiety Drugs) & By Geography -Forecast (2016-2021)

Psychotherapeutic Drugs Market: By Type (Antipsychotics, Antidepressants, Antimaniacs, and Anxiety Drugs) & By Geography -Forecast (2016-2021)

  • $ 5250
  • Industry report
  • August 2016
  • by Industry ARC

Psychotherapeutic drugs are used to treat mental illnesses such as extreme mood swings, social withdrawal, long lasting depression, confused thinking, and suicidal thought. schizophrenia, bipolar disorder, ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.